In addition to their physiological functions, disruptions in the expression and regulatory pathways of LOX family proteins have been implicated in the onset of various cancers, such as lung cancer 16, hepatocellular carcinoma 17, gastric cancer 18, and colorectal cancer 19. This evidence concerns the gene LOX and hepatocellular carcinoma.